Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Johnson & Johnson (JNJ), The Procter & Gamble Company (PG): How To Invest Despite Long-Tail Risk Part II

McDonald’s

McDonald’s Corporation (NYSE:MCD) also has a yield in the 3% area and a very low beta. However, as a fast food giant, it may be at the exact opposite side of the health spectrum.

The burger giant has well over 30,000 locations across almost 120 countries. About 80% of its restaurants are franchised. It has a leading position in developed markets and is building its business in emerging markets. Note that the franchise model reduces risk, as the company functions as a toll taker for franchisees taking on the store opening risks. A big benefit in emerging markets.

McDonald’s isn’t new to emerging markets, however. While mid-priced and expensive restaurants are a tough sell in relatively poor countries, the Golden Arches sells meals that are fairly inexpensive. This has allowed the company a first-mover advantage. Moreover, quick serve burgers are desirable across the entire wealth spectrum. So, as emerging markets become wealthier, McDonald’s top and bottom lines should benefit.

Although McDonald’s shares aren’t cheap, it is a great company and still offers a notable dividend yield backed by a long history of dividend increases.

Procter & Gamble

The Procter & Gamble Company (NYSE:PG) has been taking heat lately for an ill fated attempt to push into emerging markets. Unlike McDonald’s, the company primarily sells premium products. That’s a hard sell in countries where most of the population is relatively poor.

That said, the company is an industry leader in the consumer products space. For example, it has 25 brands that each generate more than $1 billion a year in sales. Moreover, it is broadly diversified across product categories and has a long history of innovation. It’s got problems, but its far more likely to figure them out than succumb to them.

A low beta, a dividend yield a little under 3%, and a restructuring plan to deal with its recent issues should interest most investors.

Preparing for the Worst

While you can’t fully protect yourself from a market decline, buying industry leaders with low betas can help soften the blow. Each of the companies here fits that bill. Read Part 1 of this two part article for more low-beta ideas.

The article How To Invest Despite Long-Tail Risk Part 2 originally appeared on Fool.com and is written by Reuben Brewer.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.